144 ·Filed May 4, 2026
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral
Routine insider sale under a pre-arranged 10b5-1 plan with minimal dollar value. No trading action warranted. Monitor any future unplanned insider selling for potential change in sentiment.
Final — all horizons settled through T+60d ⚠ clustered
TRDA ▼ -57.02% at T+60d
NEUTRAL call ✗ call lost -57.02% · α vs SPY -59.76% · entry $15.75 → $6.77
T+1d
+1.78%
call +1.78% · α +0.39%
$16.03
settled 5mo ago
T+5d
-54.79%
call -54.79% · α -56.78%
$7.12
settled 5mo ago
T+20d
-57.84%
call -57.84% · α -62.80%
$6.64
settled 4mo ago
T+60d
-57.02%
call -57.02% · α -59.76%
$6.77
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Officer Nathan Dowden filed Form 144 to sell 15,000 shares (approx. $217,500) under a 10b5-1 trading plan. The sale is routine and pre-arranged, representing a small fraction of market cap. No material impact expected.
Key Facts
- Officer Nathan Dowden intends to sell 15,000 shares of common stock.
- Estimated aggregate market value: $217,500.
- Sale is proposed under a 10b5-1 trading plan, reducing informational content.
- Shares were acquired via exercise of stock options on same date.
- Prior 10b5-1 sales occurred in March 2026.
Financial Impact
$217,500 (0.04% of market cap)
dilution
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (13 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-004004 |
| Document: 0001950047-26-004004-index.html | 0001950047-26-004004 |
| Document: 0001950047-26-004004.txt | 0001950047-26-004004 |
18 reports for TRDA
50% Hit rate best @ T+60▲ +58.52%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 22d ago | Insider Cluster | $6.42 $6.90 | ▼ −7.48% | ▼ −7.98% | $5.38 (+16.20%) |
Sep 3, 2026 29d ago | Insider Cluster | $7.17 $6.80 | ▼ −5.16% | ▼ −4.01% | $5.38 (−24.97%) |
Aug 31, 2026 4w ago | Insider Cluster | $7.07 $7.11 | ▲ +0.57% | ▲ +0.48% | $5.38 (−23.90%) |
Aug 31, 2026 4w ago | Insider Cluster | $7.07 $7.11 | ▲ +0.57% | ▲ +0.48% | $5.38 (−23.90%) |
Aug 31, 2026 4w ago | Insider Cluster | $7.07 $7.11 | ▲ +0.57% | ▲ +0.48% | $5.38 (−23.90%) |
Aug 27, 2026 5w ago | Insider Cluster | $7.27 $7.17 | ▼ −1.38% | ▼ −1.64% | $5.38 (−26.00%) |
Aug 10, 2026 7w ago | Insider Cluster | $7.04 $7.27 | ▲ +3.27% | ▲ +3.67% | $5.38 (−23.58%) |
Aug 5, 2026 8w ago | 8-K | $7.06 $7.67 | ▲ +8.64% | ▲ +8.29% | $5.38 (−23.80%) |
Aug 3, 2026 8w ago | Insider Cluster | $7.24 $7.04 | ▼ −2.76% | ▼ −2.66% | $5.38 (−25.69%) |
Jul 30, 2026 9w ago | 144 | $6.79 $6.87 | ▼ −1.18% | ▲ +2.33% | $5.38 (+20.77%) |
Showing 10 of 18
US Market Status
Market Closed — Opens Mon (64h 7m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access